Chester County News and Community Website
RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) recently shared its financials and offered updates on its business operations from the first quarter of 2024. On the financial front, the pharmaceutical …
NRx Pharmaceuticals Holds Promise for Investors and Patients Alike Read More RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) will attend the EF Hutton Annual Global Conference on May 15, 2024, at The Plaza Hotel, New York City.
NRx Pharmaceuticals to Engage Investors at EF Hutton Annual Global Conference Read More RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) recently highlighted a compelling advantage in safety for its drug NRX-101, in comparison to the standard treatments offered in its latest clinical trial. …
NRx Pharmaceuticals Makes Significant Stride with New Depression Drug, Aims for Accelerated FDA Approval Read More RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) disclosed encouraging preliminary outcomes from a study on NRX-101, an investigational drug designated as a breakthrough therapy. The drug demonstrated a promising, …
NRx Pharmaceuticals Breakthrough Drug Shows Potential to Reduce Suicide Risk in Bipolar Depression Patients Read More